Classic Kaposi's sarcoma associated with human herpesvirus 8 infection in a 13-year-old male: A case report

Clinical Cancer Research

Volumn 7, Issue 8, 2001, Pages 2263-2268

  Landau, Heather J ^a   Poiesz, Bernard J ^a   Dube, Samalima ^a   Bogart, Jeffrey A ^a   Weiner, Leonard B ^a   Souid, Abdul Kader ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; IMMUNOGLOBULIN G; PREDNISONE; RECOMBINANT ALPHA2A INTERFERON;

ADOLESCENT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DNA SEQUENCE; DRUG EFFICACY; DRUG TOLERABILITY; GENE AMPLIFICATION; HERPES; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; LEUKOPENIA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; THROMBOCYTOPENIA;

ADOLESCENT; ANTIVIRAL AGENTS; BASE SEQUENCE; DNA, VIRAL; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INTERFERON-ALPHA; MALE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SARCOMA, KAPOSI; SEQUENCE HOMOLOGY, NUCLEIC ACID; SKIN; SKIN NEOPLASMS;

EID: 0034880886     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Idiopathiches multiples pigment sarcom der Haut
2. Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8: An overview
3. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
4. Detection of herpesvirus-like DNA by nested PCR on archival skin biopsy specimens of various forms of Kaposi's sarcoma
5. Human herpesvirus 8 in Italian HIV-seronegative patients with Kaposi sarcoma
6. Herpes virus-like sequences are specifically found in Kaposi's sarcoma lesions
7. Herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with Mediterranean Kaposi's sarcoma
8. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection
9. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients
10. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma
11. Strain variability among Kaposi's sarcoma-associated (human herpesvirus 8) herpesvirus genomes: Evidence that a large cohort of United States AIDS patients may have been infected by a single common isolate
12. High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations
13. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients
14. Detection of human herpesvirus 8 DNA sequences in tissues and bodily fluids
15. Comparison of human immunodeficiency virus 1 DNA polymerase chain reaction and qualitative and quantitative RNA polymerase chain reaction in human immunodeficiency virus 1-exposed infants
16. Acquired immunodeficiency syndrome-like illness associated with systemic Mycoplasma fermentans infection in a human immunodeficiency virus-negative homosexual man
17. Comparative performances of the Abbott HTLV-I/HTLV-IIEIA to other serological and PCR assays on samples from persons at risk for HTLV-II infection
18. Kaposi's sarcoma: A clinicopathological study with particular reference to its relationship to the reticuloendothelial system
19. Clinical manifestations of classic, endemic African, and epidemic AIDS-associated Kaposi's sarcoma
20. Kaposi's sarcoma, epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy
21. KSHV antibodies among Americans, Italians, and Ugandans with and without Kaposi's sarcoma
22. Sexual transmission and the natural history of human herpesvirus 8 infection
23. Serologic evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus infection
24. Kaposi's sarcoma associated herpes virus (KSHV/HHV 8) epidemiology, molecular biology, and tissue distribution
25. Kaposi's sarcoma, retrospective study of 90 cases with particular emphasis on the familial occurrence, ethnic background and prevalence of other diseases
26. Classic Kaposi sarcoma. Experience at Rabin Medical Center in Israel
27. Analysis of T cell subsets in different clinical subgroups of patients with the acquired immune deficiency syndrome. Comparison with the "classic" form of Kaposi's sarcoma
28. Classic Kaposi's sarcoma. T-lymphocyte subsets, T4/T8 ratio, and KN cell activity
29. Kaposi's sarcoma in infants and children
30. Primary Kaposi's sarcoma of the lymph node in children
31. Uber ein besonderes fibrohamangiombildenesdes syndrom der lymphdrusen und der haut, das in beziehung zur gruppe der "sarcomatosis Kaposi" steht
32. Childhood Kaposi's sarcoma in Papua New Guinea
33. Juvenile classic Kaposi's sarcoma: A report of two cases, one with family history
34. Hepatic Kaposi sarcoma in AIDS: US and CT findings
35. Combined autoimmune cytopenias
36. Proceedings. Kaposi sarcoma in African children
37. Genetically determined coincidence of Kaposi's sarcoma and psoriasis in an HIV-negative patient after prednisolone treatment. Spontaneous regression 8 months after discontinuation of therapy
38. Kaposi's sarcoma in recipients of renal transplants
39. Clinical effect of glucocortocoid on Kaposi's sarcoma related to the acquired immunodeficiency syndrome (AIDS)
40. Tailoring treatment for classical Kaposi's sarcoma: Comprehensive clinical guidelines
41. Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon α-2b
42. Classic Kaposi's sarcoma: Low-dose interferon α treatment
43. Regression of Kaposi sarcoma after intravenous immunoglobulin treatment for polymyositis
44. Treatment of Kaposi's sarcoma
45. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma
46. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma
47. Pegylated-liposomal doxorubicin versus doxorubicin, of AIDS-related Kaposi's sarcoma: Results of a randomized Phase III clinical trial